To ask Her Majesty's Government what proportion of the overall Research and Development funding uplift announced in the Spending Review will go to the National Institute for Health Research.
Answered on
11 November 2021
The Spending Review settlement provides £5 billion over the Spending Review period for health-related research and development (R&D). This includes the largest funding received by health R&D, with an increase of £605 million on 2020-21 funding by 2024-25 which means the investment will rise to £2 billion by the end of the Spending Review period.
The National Institute for Health Research budget will be finalised as part of a detailed financial planning process. The distribution of capital across health R&D areas will be confirmed before funding is made available in April 2022.